Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe Direct-to-Consumer Laboratory Testing Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)
5.2. Disease Prevalence & Incidence Rate
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017–2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type

7. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017–2031
7.3.1. Genetic Testing
7.3.1.1. Nutrigenetics Test
7.3.1.1.1. Weight Control
7.3.1.1.2. Lactose Intolerance
7.3.1.1.3. Others
7.3.1.2. Celiac Disease Test
7.3.1.3. Sports & Physical Activity Testing
7.3.1.4. Men’s Health Tests
7.3.1.5. Women’s Health Tests
7.3.1.6. Pregnancy & Prenatal Screening Test
7.3.1.7. General Health Testing
7.3.1.8. Others
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Sexual Health Tests
7.3.2.1.1. HIV
7.3.2.1.2. Chlamydia
7.3.2.1.3. Others
7.3.2.2. Cancer Predisposition Tests
7.3.2.3. Others
7.3.3. CBC
7.3.4. Chronic Disease Testing
7.3.4.1. Diabetes Testing
7.3.4.2. Hypertension
7.3.4.3. Others
7.3.5. COVID-19 Testing
7.3.6. TSH Testing
7.3.7. Others
7.4. Market Attractiveness Analysis, by Test Type

8. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Provider, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Speciality Labs
8.3.4. Diagnostic Centres
8.4. Market Attractiveness Analysis, by Provider

9. Germany Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Sample Type, 2017–2031
9.2.1. Blood
9.2.2. Urine
9.2.3. Saliva
9.2.4. Others
9.3. Market Value Forecast, by Test Type, 2017–2031
9.3.1. Genetic Testing
9.3.1.1. Nutrigenetics Test
9.3.1.1.1. Weight Control
9.3.1.1.2. Lactose Intolerance
9.3.1.1.3. Others
9.3.1.2. Celiac Disease Test
9.3.1.3. Sports & Physical Activity Testing
9.3.1.4. Men’s Health Tests
9.3.1.5. Women’s Health Tests
9.3.1.6. Pregnancy & Prenatal Screening Test
9.3.1.7. General Health Testing
9.3.1.8. Others
9.3.2. Disease Risk Assessment Testing
9.3.2.1. Sexual Health Tests
9.3.2.1.1. HIV
9.3.2.1.2. Chlamydia
9.3.2.1.3. Others
9.3.2.2. Cancer Predisposition Tests
9.3.2.3. Others
9.3.3. CBC
9.3.4. Chronic Disease Testing
9.3.4.1. Diabetes Testing
9.3.4.2. Hypertension
9.3.4.3. Others
9.3.5. COVID-19 Testing
9.3.6. TSH Testing
9.3.7. Others
9.4. Market Value Forecast, by Provider, 2017–2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Speciality Labs
9.4.4. Diagnostic Centres

10. U.K. Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Sample Type, 2017–2031
10.2.1. Blood
10.2.2. Urine
10.2.3. Saliva
10.2.4. Others
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Genetic Testing
10.3.1.1. Nutrigenetics Test
10.3.1.1.1. Weight Control
10.3.1.1.2. Lactose Intolerance
10.3.1.1.3. Others
10.3.1.2. Celiac Disease Test
10.3.1.3. Sports & Physical Activity Testing
10.3.1.4. Men’s Health Tests
10.3.1.5. Women’s Health Tests
10.3.1.6. Pregnancy & Prenatal Screening Test
10.3.1.7. General Health Testing
10.3.1.8. Others
10.3.2. Disease Risk Assessment Testing
10.3.2.1. Sexual Health Tests
10.3.2.1.1. HIV
10.3.2.1.2. Chlamydia
10.3.2.1.3. Others
10.3.2.2. Cancer Predisposition Tests
10.3.2.3. Others
10.3.2.4. CBC
10.3.2.5. Chronic Disease Testing
10.3.2.5.1. Diabetes Testing
10.3.2.5.2. Hypertension
10.3.2.5.3. Others
10.3.2.6. COVID-110 Testing
10.3.2.7. TSH Testing
10.3.2.8. Others
10.4. Market Value Forecast, by Provider, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Speciality Labs
10.4.4. Diagnostic Centres

11. France Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Sample Type, 2017–2031
11.2.1. Blood
11.2.2. Urine
11.2.3. Saliva
11.2.4. Others
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Genetic Testing
11.3.1.1. Nutrigenetics Test
11.3.1.1.1. Weight Control
11.3.1.1.2. Lactose Intolerance
11.3.1.1.3. Others
11.3.1.2. Celiac Disease Test
11.3.1.3. Sports & Physical Activity Testing
11.3.1.4. Men’s Health Tests
11.3.1.5. Women’s Health Tests
11.3.1.6. Pregnancy & Prenatal Screening Test
11.3.1.7. General Health Testing
11.3.1.8. Others
11.3.2. Disease Risk Assessment Testing
11.3.2.1. Sexual Health Tests
11.3.2.1.1. HIV
11.3.2.1.2. Chlamydia
11.3.2.1.3. Others
11.3.2.2. Cancer Predisposition Tests
11.3.2.3. Others
11.3.3. CBC
11.3.4. Chronic Disease Testing
11.3.4.1. Diabetes Testing
11.3.4.2. Hypertension
11.3.4.3. Others
11.3.5. COVID-19 Testing
11.3.6. TSH Testing
11.3.7. Others
11.4. Market Value Forecast, by Provider, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Speciality Labs
11.4.4. Diagnostic Centres
12. Italy Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Sample Type, 2017–2031
12.2.1. Blood
12.2.2. Urine
12.2.3. Saliva
12.2.4. Others
12.3. Market Value Forecast, by Test Type, 2017–2031
12.3.1. Genetic Testing
12.3.1.1. Nutrigenetics Test
12.3.1.1.1. Weight Control
12.3.1.1.2. Lactose Intolerance
12.3.1.1.3. Others
12.3.1.2. Celiac Disease Test
12.3.1.3. Sports & Physical Activity Testing
12.3.1.4. Men’s Health Tests
12.3.1.5. Women’s Health Tests
12.3.1.6. Pregnancy & Prenatal Screening Test
12.3.1.7. General Health Testing
12.3.1.8. Others
12.3.2. Disease Risk Assessment Testing
12.3.2.1. Sexual Health Tests
12.3.2.1.1. HIV
12.3.2.1.2. Chlamydia
12.3.2.1.3. Others
12.3.2.2. Cancer Predisposition Tests
12.3.2.3. Others
12.3.3. CBC
12.3.4. Chronic Disease Testing
12.3.4.1. Diabetes Testing
12.3.4.2. Hypertension
12.3.4.3. Others
12.3.5. COVID-19 Testing
12.3.6. TSH Testing
12.3.7. Others
12.4. Market Value Forecast, by Provider, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Speciality Labs
12.4.4. Diagnostic Centres

13. Spain Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Sample Type, 2017–2031
13.2.1. Blood
13.2.2. Urine
13.2.3. Saliva
13.2.4. Others
13.3. Market Value Forecast, by Test Type, 2017–2031
13.3.1. Genetic Testing
13.3.1.1. Nutrigenetics Test
13.3.1.1.1. Weight Control
13.3.1.1.2. Lactose Intolerance
13.3.1.1.3. Others
13.3.1.2. Celiac Disease Test
13.3.1.3. Sports & Physical Activity Testing
13.3.1.4. Men’s Health Tests
13.3.1.5. Women’s Health Tests
13.3.1.6. Pregnancy & Prenatal Screening Test
13.3.1.7. General Health Testing
13.3.1.8. Others
13.3.2. Disease Risk Assessment Testing
13.3.2.1. Sexual Health Tests
13.3.2.1.1. HIV
13.3.2.1.2. Chlamydia
13.3.2.1.3. Others
13.3.2.2. Cancer Predisposition Tests
13.3.2.3. Others
13.3.3. CBC
13.3.4. Chronic Disease Testing
13.3.4.1. Diabetes Testing
13.3.4.2. Hypertension
13.3.4.3. Others
13.3.5. COVID-19 Testing
13.3.6. TSH Testing
13.3.7. Others
13.4. Market Value Forecast, by Provider, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Speciality Labs
13.4.4. Diagnostic Centres

14. Rest of Europe Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Sample Type, 2017–2031
14.2.1. Blood
14.2.2. Urine
14.2.3. Saliva
14.2.4. Others
14.3. Market Value Forecast, by Test Type, 2017–2031
14.3.1. Genetic Testing
14.3.1.1. Nutrigenetics Test
14.3.1.1.1. Weight Control
14.3.1.1.2. Lactose Intolerance
14.3.1.1.3. Others
14.3.1.2. Celiac Disease Test
14.3.1.3. Sports & Physical Activity Testing
14.3.1.4. Men’s Health Tests
14.3.1.5. Women’s Health Tests
14.3.1.6. Pregnancy & Prenatal Screening Test
14.3.1.7. General Health Testing
14.3.1.8. Others
14.3.2. Disease Risk Assessment Testing
14.3.2.1. Sexual Health Tests
14.3.2.1.1. HIV
14.3.2.1.2. Chlamydia
14.3.2.1.3. Others
14.3.2.2. Cancer Predisposition Tests
14.3.2.3. Others
14.3.3. CBC
14.3.4. Chronic Disease Testing
14.3.4.1. Diabetes Testing
14.3.4.2. Hypertension
14.3.4.3. Others
14.3.5. COVID-19 Testing
14.3.6. TSH Testing
14.3.7. Others
14.4. Market Value Forecast, by Provider, 2017–2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Speciality Labs
14.4.4. Diagnostic Centres

15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. 23andMe, Inc.
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Ancestry
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. SWOT Analysis
15.2.3. CircleDNA
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Eurofins Scientific
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.5. Family Tree DNA (Gene by Gene)
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. SWOT Analysis
15.2.6. Laboratory Corporation of America Holdings
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Living DNA Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. SWOT Analysis
15.2.8. Medichecks.com Ltd.
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
15.2.9. MyHeritage Ltd.
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. SWOT Analysis
15.2.10. MyMedLab, Inc.
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. SWOT Analysis
15.2.11. Quest Diagnostics Incorporated
15.2.11.1. Company Description
15.2.11.2. Business Overview
15.2.11.3. Financial Overview
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis



List of Figures

List of Figures

Figure 01: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 02: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 07: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 08: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 10: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

Figure 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

Figure 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 16: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 17: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 18: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 19: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

Figure 20: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

Figure 21: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 22: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 24: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 25: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 26: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 27: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 28: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 29: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 31: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 32: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 33: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 34: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 35: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 36: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 37: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 38: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 39: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 40: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 41: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 42: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 43: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 44: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 45: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 46: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 47: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 48: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 49: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 50: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 51: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 52: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 53: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 54: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 55: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 56: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

List of Tables

List of Tables

Table 01: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 33: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 34: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 35: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 36: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 37: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 38: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 39: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 40: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 41: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 42: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 43: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 44: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 45: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 46: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 47: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 48: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 49: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 50: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 51: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 52: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 53: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 54: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 55: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 56: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031